MAT

Zydus receives USFDA approval for ZITUVIO™ to treat adult patients with type 2 diabetes mellitus

Retrieved on: 
Friday, October 20, 2023

AHMEDABAD, India, Oct. 20, 2023 /PRNewswire/ -- Zydus Lifesciences Limited (including its subsidiaries/affiliates, hereafter referred to as 'Zydus') today announced that the U.S. Food and Drug Administration (FDA) approved its New Drug Application (NDA) for ZITUVIO™ (Sitagliptin) tablets, 25 mg, 50 mg, and 100 mg.

Key Points: 
  • The approval of ZITUVIO™ is based on research, development, regulatory and manufacturing work performed by Zydus teams.
  • ZITUVIO™ has undergone quality testing for Nitrosamines and potential genotoxic impurities as per current USFDA standards.
  • "The ZITUVIO™ approval builds on Zydus' long-term commitment to offer healthcare professionals a new affordable treatment option in connection with diabetes management," said Dr. Sharvil Patel, Managing Director of Zydus Lifesciences Limited.
  • "We are pleased to be able to receive such a milestone approval for Zydus.

Pioneering Transformation: Unveiling the Trailblazing Winners of the Inaugural WiT Travel Changemakers Awards 2023

Retrieved on: 
Thursday, October 5, 2023

10 Innovative Organisations are honoured for transforming their propositions with technology, paving the way forward for the APAC Travel Industry

Key Points: 
  • 10 Innovative Organisations are honoured for transforming their propositions with technology, paving the way forward for the APAC Travel Industry
    SINGAPORE, Oct 5, 2023 - (ACN Newswire) - The Asia Travel Technology Industry Association (ATTIA) and Web in Travel (WiT) are delighted to announce the winners of the inaugural Travel Changemakers Awards 2023.
  • "Bringing action to our thoughts, we focused on common elements - the environment, empowering local communities, nurturing talent - which led to the creation of the Travel Changemakers Awards 2023.
  • We are thrilled to have the Asia Travel & Tech Industry Association's support for this inaugural event.
  • Tourism Board: "Being part of the judging panel for the WiT Travel Changemakers Awards has been an eye-opening experience.

Mattel Announces Third Quarter 2023 Financial Results and Conference Call Date

Retrieved on: 
Wednesday, October 4, 2023

Mattel, Inc. (NASDAQ: MAT) today announced that it plans to release its third quarter 2023 financial results on Wednesday, October 25, 2023, at approximately 4:05 p.m. Eastern Time.

Key Points: 
  • Mattel, Inc. (NASDAQ: MAT) today announced that it plans to release its third quarter 2023 financial results on Wednesday, October 25, 2023, at approximately 4:05 p.m. Eastern Time.
  • Following this, Mattel will host a webcast conference call at 5:00 p.m. Eastern Time.
  • The webcast and accompanying slides will be available under the Events and Presentations section of Mattel's Investor Relations website, https://investors.mattel.com .
  • An archive of the webcast will be available on the Company's website for 12 months following the event.

Mattel Promotes Robbie Brenner to President of Mattel Films

Retrieved on: 
Wednesday, September 27, 2023

Mattel, Inc. (NASDAQ: MAT) today announced the promotion of Robbie Brenner to President of Mattel Films.

Key Points: 
  • Mattel, Inc. (NASDAQ: MAT) today announced the promotion of Robbie Brenner to President of Mattel Films.
  • She was previously Executive Producer of Mattel Films since 2018.
  • View the full release here: https://www.businesswire.com/news/home/20230927993899/en/
    Robbie Brenner, President of Mattel Films (Photo: Business Wire)
    Ynon Kreiz, Chairman and CEO of Mattel, said: “Robbie joined the company five years ago to bring the vision of Mattel Films to life, collaborating with leading filmmakers to make standout quality movies based on our iconic brands that will resonate in culture and appeal to global audiences.
  • Mattel Films is also developing Christmas Balloon, a holiday family drama based on all-new IP.

Fora Health Joins Forces with Other Addiction Treatment Facilities for Walk for Recovery Event

Retrieved on: 
Wednesday, September 20, 2023

Portland, OR, Sept. 20, 2023 (GLOBE NEWSWIRE) -- Fora Health Treatment and Recovery, an alcohol and drug addiction recovery center located in Portland, Oregon, joined forces with "Go the Distance," CODA Treatment Recovery (Comprehensive Options for Drug Addicts), and Volunteers of America (VOA) to participate in the annual Walk for Recovery event organized by Oregon Recovers .

Key Points: 
  • Portland, OR, Sept. 20, 2023 (GLOBE NEWSWIRE) -- Fora Health Treatment and Recovery, an alcohol and drug addiction recovery center located in Portland, Oregon, joined forces with "Go the Distance," CODA Treatment Recovery (Comprehensive Options for Drug Addicts), and Volunteers of America (VOA) to participate in the annual Walk for Recovery event organized by Oregon Recovers .
  • Walk for Recovery, the flagship fundraising event of Oregon Recovers stands as a pivotal initiative in our battle against Oregon's addiction crisis.
  • With a primary fundraising target of $100,000, the event aims to provide critical resources to tackle this pressing issue.
  • The walk followed a route of approximately two miles, passing by various treatment providers, recovery houses, detox centers, and Medication-Assisted Treatment (MAT) clinics.

Intravacc announces publication of In Vitro alternative to replace animal pyrogen test for vaccines

Retrieved on: 
Tuesday, September 19, 2023

However, vaccine safety is of paramount importance, and researchers are continually exploring innovative methods to ensure that new vaccines are both effective and safe.

Key Points: 
  • However, vaccine safety is of paramount importance, and researchers are continually exploring innovative methods to ensure that new vaccines are both effective and safe.
  • The MAT is an in vitro assay that can replace the rabbit pyrogen test.
  • The article entitled “In vitro alternative for reactogenicity assessment of outer membrane vesicle based vaccines” is published in the peer reviewed journal of Scientific Reports, volume 13, 2023.
  • The MAT also proved its applicability to assess reactogenicity levels of pyrogen containing vaccines at multiple stages of vaccine development and could eventually replace RPT.

Ophelia and Vori Health Partner to Address Pain Management for Patients with Musculoskeletal Conditions

Retrieved on: 
Friday, September 22, 2023

MSK pain is one of the primary reasons why opioids are prescribed to patients, often by primary care physicians who are not typically trained in appropriate, evidence-based MSK care.

Key Points: 
  • MSK pain is one of the primary reasons why opioids are prescribed to patients, often by primary care physicians who are not typically trained in appropriate, evidence-based MSK care.
  • If the Vori Health care team has a patient who reports opioid addiction, they can be referred to Ophelia.
  • Conversely, if an Ophelia patient expresses concern about MSK pain and is looking for non-opioid treatment options, clinicians can refer them to Vori Health for care.
  • "By offering virtual care solutions, Vori Health can provide patients with access to evidence-based specialty care for MSK pain that cuts opioids out of the equation," said Dr. Ryan Grant , co-founder and CEO, Vori Health.

Ohio Locking Vial Program Designated Best Practice for MAT/MOUD Treatment by Leading Public Health Organization

Retrieved on: 
Tuesday, September 19, 2023

The intervention was also selected for a "Best of the Best Presentation" at the NACCHO 360 annual conference.

Key Points: 
  • The intervention was also selected for a "Best of the Best Presentation" at the NACCHO 360 annual conference.
  • The intervention indicated that the use of locking prescription vials (LPVs) reduced one of the common barriers for patient participation in MOUD programs, which include accessibility, stigma, and medication safety.
  • "The intent of the intervention was to see if locking vials could be used as a tool to decrease diversion and increase patient safety and confidence.
  • "As a prescriber, I feel much more confident using the locking prescription vial for the safety of young children and families in my community.

KCSA Elevates Agency Veteran Danielle DeVoren to Managing Partner

Retrieved on: 
Thursday, September 14, 2023

NEW YORK, Sept. 14, 2023 /PRNewswire/ -- For the first time in nearly 15 years, KCSA Strategic Communications (the "Firm") has named Danielle DeVoren as Managing Partner. KCSA is one of the leading, independent integrated public relations, investor relations and social media organizations in the United States, serving clients for 54 years.

Key Points: 
  • First New Managing Partner in Nearly 15 Years to Help Grow KCSA's PR and Social Media Divisions Across Industry Verticals with a Focus on Media, Advertising, Technology, and Financial Services
    NEW YORK, Sept. 14, 2023 /PRNewswire/ -- For the first time in nearly 15 years, KCSA Strategic Communications (the "Firm") has named Danielle DeVoren as Managing Partner.
  • In her previous role as Managing Director, Danielle has launched and grown its Media, Advertising and Technology (MAT) practice into one the Firm's largest divisions today.
  • "Danielle is one of our top performing revenue drivers and serves as a change agent, ensuring that KCSA remains at the forefront of the communications industry.
  • Danielle began her career in 2005 as an Assistant Account Executive for KCSA.

Northern Illinois Recovery Center Recognized as a Top Treatment Center in the Nation by Newsweek

Retrieved on: 
Tuesday, September 12, 2023

CRYSTAL LAKE, Ill., Sept. 12, 2023 /PRNewswire/ -- Northern Illinois Recovery Center has been recognized as one of America's Best Addiction Treatment Centers in 2023 by Newsweek.

Key Points: 
  • CRYSTAL LAKE, Ill., Sept. 12, 2023 /PRNewswire/ -- Northern Illinois Recovery Center has been recognized as one of America's Best Addiction Treatment Centers in 2023 by Newsweek.
  • "At Northern Illinois Recovery Center, we are committed to delivering outstanding addiction treatment services and are honored to be recognized among the best in our field," said Chris Reed, owner & managing partner of Northern Illinois Recovery Center.
  • Located not far outside Chicago, Northern Illinois Recovery Center provides unparalleled care and support for those in recovery from drug and alcohol abuse.
  • At Northern Illinois Recovery Center, clients can access treatment programs that include detox, residential or inpatient, outpatient, intensive outpatient programs (IOP), partial hospitalization programs (PHP), medication-assisted treatment (MAT), and dual diagnosis.